retatrutide clinical trial phase Retatrutide: FDA approval time, results & weight loss Retatrutide for weight loss: Study

Customers cant always be sure that whats on the label matches whats in the vial

If you are pregnant or suspect pregnancy GLP-1 medications are contraindicated during pregnancy

For people without insurance coverage, compounded semaglutide is often a financially accessible option

Generic alternatives to Ozempic are expected to become available within the next decade

These diseases have persistently and stubbornly increased through the decades, through various dietary trends and public health interventions

According to FDA guidance, GLP-1 medications are not recommended for people who have: Pregnancy, because safety data are limited and pregnancy requires appropriate weight gain and nutrient storage A prior history of pancreatitis, due to a risk of triggering inflammation of the pancreas A history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2), a rare genetic condition linked to thyroid cancer in animal studies A clinician will review your medical history carefully to determine whether these medications are appropriate for you